367 related articles for article (PubMed ID: 11722623)
1. Control of T-cell activation by CD4+ CD25+ suppressor T cells.
Shevach EM; McHugh RS; Piccirillo CA; Thornton AM
Immunol Rev; 2001 Aug; 182():58-67. PubMed ID: 11722623
[TBL] [Abstract][Full Text] [Related]
2. CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells.
Suri-Payer E; Amar AZ; Thornton AM; Shevach EM
J Immunol; 1998 Feb; 160(3):1212-8. PubMed ID: 9570536
[TBL] [Abstract][Full Text] [Related]
3. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance.
Itoh M; Takahashi T; Sakaguchi N; Kuniyasu Y; Shimizu J; Otsuka F; Sakaguchi S
J Immunol; 1999 May; 162(9):5317-26. PubMed ID: 10228007
[TBL] [Abstract][Full Text] [Related]
4. T lymphocyte-mediated control of autoimmunity.
Shevach EM; Thornton A; Suri-Payer E
Novartis Found Symp; 1998; 215():200-11; discussion 211-30. PubMed ID: 9760581
[TBL] [Abstract][Full Text] [Related]
5. Activation requirements for the induction of CD4+CD25+ T cell suppressor function.
Thornton AM; Piccirillo CA; Shevach EM
Eur J Immunol; 2004 Feb; 34(2):366-76. PubMed ID: 14768041
[TBL] [Abstract][Full Text] [Related]
6. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state.
Takahashi T; Kuniyasu Y; Toda M; Sakaguchi N; Itoh M; Iwata M; Shimizu J; Sakaguchi S
Int Immunol; 1998 Dec; 10(12):1969-80. PubMed ID: 9885918
[TBL] [Abstract][Full Text] [Related]
7. Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro.
Stephens LA; Mottet C; Mason D; Powrie F
Eur J Immunol; 2001 Apr; 31(4):1247-54. PubMed ID: 11298351
[TBL] [Abstract][Full Text] [Related]
8. Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10.
Zheng SG; Wang JH; Gray JD; Soucier H; Horwitz DA
J Immunol; 2004 May; 172(9):5213-21. PubMed ID: 15100259
[TBL] [Abstract][Full Text] [Related]
9. CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness.
Piccirillo CA; Letterio JJ; Thornton AM; McHugh RS; Mamura M; Mizuhara H; Shevach EM
J Exp Med; 2002 Jul; 196(2):237-46. PubMed ID: 12119348
[TBL] [Abstract][Full Text] [Related]
10. Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25- precursors.
Zheng SG; Gray JD; Ohtsuka K; Yamagiwa S; Horwitz DA
J Immunol; 2002 Oct; 169(8):4183-9. PubMed ID: 12370347
[TBL] [Abstract][Full Text] [Related]
11. Differential cytokine requirements for regulation of autoimmune gastritis and colitis by CD4(+)CD25(+) T cells.
Suri-Payer E; Cantor H
J Autoimmun; 2001 Mar; 16(2):115-23. PubMed ID: 11247637
[TBL] [Abstract][Full Text] [Related]
12. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production.
Thornton AM; Shevach EM
J Exp Med; 1998 Jul; 188(2):287-96. PubMed ID: 9670041
[TBL] [Abstract][Full Text] [Related]
13. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific.
Thornton AM; Shevach EM
J Immunol; 2000 Jan; 164(1):183-90. PubMed ID: 10605010
[TBL] [Abstract][Full Text] [Related]
14. The role of CD4+CD25+ immunoregulatory T cells in the induction of autoimmune gastritis.
Laurie KL; Van Driel IR; Gleeson PA
Immunol Cell Biol; 2002 Dec; 80(6):567-73. PubMed ID: 12406391
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells.
Zheng SG; Wang JH; Stohl W; Kim KS; Gray JD; Horwitz DA
J Immunol; 2006 Mar; 176(6):3321-9. PubMed ID: 16517699
[TBL] [Abstract][Full Text] [Related]
16. A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood.
Yamagiwa S; Gray JD; Hashimoto S; Horwitz DA
J Immunol; 2001 Jun; 166(12):7282-9. PubMed ID: 11390478
[TBL] [Abstract][Full Text] [Related]
17. Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells.
Piccirillo CA; Shevach EM
J Immunol; 2001 Aug; 167(3):1137-40. PubMed ID: 11466326
[TBL] [Abstract][Full Text] [Related]
18. Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease.
Horwitz DA; Zheng SG; Gray JD; Wang JH; Ohtsuka K; Yamagiwa S
Semin Immunol; 2004 Apr; 16(2):135-43. PubMed ID: 15036237
[TBL] [Abstract][Full Text] [Related]
19. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta.
Nakamura K; Kitani A; Strober W
J Exp Med; 2001 Sep; 194(5):629-44. PubMed ID: 11535631
[TBL] [Abstract][Full Text] [Related]
20. Control of T cell activation by CD4+CD25+ suppressor T cells.
Shevach EM; Piccirillo CA; Thornton AM; McHugh RS
Novartis Found Symp; 2003; 252():24-36; discussion 36-44, 106-14. PubMed ID: 14609210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
